Re: ESPR
|
|
Resverlogix Corp.
|
Jun 07, 2016 05:54PM
|
Re: Managing the message
|
5
|
Resverlogix Corp.
|
Jun 08, 2016 09:25AM
|
Q2 2016 Slide Deck from BIO International 2016
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 08, 2016 01:19PM
|
Re: Hide the Ball
|
3
|
Resverlogix Corp.
|
Jun 09, 2016 10:48AM
|
Updates from RH
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 09, 2016 11:04AM
|
More sites now recruiting for ZEN003694 NCT02705469 trial
|
4
|
Zenith Epigenetics
|
Jun 09, 2016 01:27PM
|
New content on Publications page of RVX website
|
4
|
Resverlogix Corp.
|
Jun 09, 2016 01:37PM
|
Re: New content on Publications page of RVX website
|
4
|
Resverlogix Corp.
|
Jun 09, 2016 02:13PM
|
Resverlogix Announces Corporate Update Webcast
|
2
|
Resverlogix Corp.
|
Jun 09, 2016 02:19PM
|
Re: More sites now recruiting for ZEN003694 NCT02705469 trial
|
2
|
Zenith Epigenetics
|
Jun 09, 2016 02:31PM
|
Slides from Resverlogix Corporate Update 6/13/16
|
|
Resverlogix Corp.
|
Jun 13, 2016 01:29PM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 01:41PM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 01:51PM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 03:54PM
|
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Zenith Epigenetics
|
Jun 13, 2016 04:27PM
|
New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 04:30PM
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
2
|
Resverlogix Corp.
|
Jun 13, 2016 05:10PM
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 05:36PM
|
The new competitors: SGLT2 inhibitors and GLP-1 Receptor Agonists
|
6
|
Resverlogix Corp.
|
Jun 13, 2016 11:43PM
|
Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
|
3
|
Resverlogix Corp.
|
Jun 13, 2016 11:46PM
|